(marketscreener.com) SAN CARLOS, Calif., Jan. 09, 2023 -- Atreca, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced the appointment of Philippe Bishop, MD, as Chief Medical Officer , effective immediately. ...https//www.marketscreener.com/quote/stock/ATRECA-INC-59968119/news/Atreca-Appoints-Philippe-Bishop-MD-as-Chief-Medical-Officer-42692523/?utm_medium=RSS&utm_content=20230109